Related Experiment Video

Updated: Jul 11, 2026

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines
05:33

High-Throughput Cellular Profiling of Targeted Protein Degradation Compounds Using HiBiT CRISPR Cell Lines

Published on: November 9, 2020

Degradation of HER2 by Cbl-based chimeric ubiquitin ligases

Xia Li1, Liangliang Shen, Jing Zhang

  • 1State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, The Fourth Military Medical University, Xi'an, China.

Cancer Research
|September 19, 2007
PubMed

Insights

Researchers developed novel Cbl-based chimeric ubiquitin ligases to target and degrade HER2 (Human Epidermal growth factor Receptor 2) in cancer. This approach effectively inhibited cancer cell growth and tumorigenicity, offering a new therapeutic strategy for HER2-overexpressing cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Targeting disease-causing proteins via ubiquitination and degradation is a promising cancer therapy.
  • HER2 overexpression is implicated in various aggressive cancers, driving tumor growth and progression.

Purpose of the Study:

  • To design and evaluate novel Cbl-based chimeric ubiquitin ligases for targeted HER2 degradation.
  • To assess the therapeutic potential of these chimeric molecules in HER2-overexpressing cancer models.

Main Methods:

  • Recombination of Cbl-based chimeric ubiquitin ligases with modified Src homology 2 domains.
  • Introduction of chimeric proteins into HER2-overexpressing breast (SK-BR-3) and ovarian (SK-OV-3) cancer cells.
  • Assessment of HER2 ubiquitination, degradation, cell cycle progression, and tumorigenicity.

Main Results:

  • Chimeric molecules effectively interacted with and enhanced the down-regulation of endogenous HER2.
  • HER2 ubiquitination and degradation were significantly promoted in a RING finger domain-dependent manner.
  • Expression of chimeric molecules inhibited colony formation, increased G1 cell cycle proportion, and suppressed tumorigenicity.

Conclusions:

  • Cbl-based chimeric ubiquitin ligases represent a novel strategy for targeted HER2 degradation.
  • These engineered ligases demonstrate potential for the targeted therapy of HER2-overexpressing cancers.
  • The findings support the development of these molecules as a new therapeutic avenue in oncology.

More Related Videos

In Vitro Analysis of E3 Ubiquitin Ligase Function06:06

In Vitro Analysis of E3 Ubiquitin Ligase Function

Published on: May 14, 2021

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs10:44

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

Related Concept Videos

Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3 (ubiquitin...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...